Use of mineralocorticoid receptor antagonist in ST elevation myocardial infarction

被引：1
|
作者：
Khan, Muhammad H. [1 ]
Gerson, Myron C. [2 ,3 ]
机构：
[1] Univ Cincinnati, Dept Internal Med, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Dept Cardiovasc Med, Cincinnati, OH 45267 USA
[3] Univ Cincinnati, Coll Med, Dept Internal Med, Div Cardiovasc Hlth & Dis, 231 Albert Sabin Way, Cincinnati, OH 45267 USA
来源：
JOURNAL OF NUCLEAR CARDIOLOGY | 2022年 / 29卷 / 05期
关键词：
SYMPATHETIC-NERVE ACTIVITY; HEART-FAILURE; SPIRONOLACTONE; DYSFUNCTION; DENERVATION; EPLERENONE;
D O I：
10.1007/s12350-021-02801-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2336 / 2339
页数：4
相关论文
共 50 条
  • [31] Mineralocorticoid receptor antagonists in patients with acute myocardial infarction - A systematic review and meta-analysis of randomized trials
    Bossard, Matthias
    Binbraik, Yasser
    Beygui, Farzin
    Pitt, Bertram
    Zannad, Faiez
    Montalescot, Gilles
    Jolly, Sanjit S.
    AMERICAN HEART JOURNAL, 2018, 195 : 60 - 69
  • [32] Retrospective review of in hospital use of mineralocorticoid receptor antagonists for high risk patients following myocardial infarction
    Robert J. H. Miller
    Jonathan G. Howlett
    BMC Cardiovascular Disorders, 15
  • [33] REPLY: Mineralocorticoid Receptor Antagonism in Acute Myocardial Infarction Who Benefits?
    Beygui, Farzin
    Montalescot, Gilles
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (20) : 2241 - 2242
  • [34] Effect of a selective aldosterone receptor antagonist in myocardial infarction
    Delyani, JA
    Robinson, EL
    Rudolph, AE
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 281 (02): : H647 - H654
  • [35] Mineralocorticoid Receptor Antagonists Modulate Galectin-3 and Interleukin-33/ST2 Signaling in Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction
    Lax, Antonio
    Sanchez-Mas, Jesus
    Asensio-Lopez, Maria C.
    Fernandez-Del Palacio, Maria J.
    Caballero, Luis
    Garrido, Iris P.
    Pastor-Perez, Francisco J.
    Januzzi, James L.
    Pascual-Figal, Domingo A.
    JACC-HEART FAILURE, 2015, 3 (01) : 50 - 58
  • [36] Changes in fractalkine in patients with ST-elevation myocardial infarction
    Yao, Kang
    Zhang, Shuning
    Lu, Hao
    Hong, Xiaowu
    Qian, Juying
    Sun, Aijun
    Zou, Yunzeng
    Ge, Junbo
    CORONARY ARTERY DISEASE, 2015, 26 (06) : 516 - 520
  • [37] A single dose of erythropoietin in ST-elevation myocardial infarction
    Voors, Adriaan A.
    Belonje, Anne M. S.
    Zijlstra, Felix
    Hillege, Hans L.
    Anker, Stefan D.
    Slart, Riemer H. J. A.
    Tio, Rene A.
    Van't Hof, Arnoud
    Jukema, J. Wouter
    Peels, Hans Otto J.
    Henriques, Jose P. S.
    ten Berg, Jurrien M.
    Vos, Jeroen
    van Gilst, Wiek H.
    van Veldhuisen, Dirk J.
    EUROPEAN HEART JOURNAL, 2010, 31 (21) : 2593 - 2600
  • [38] Myocardial Mineralocorticoid Receptor Activation by Stretching and Its Functional Consequences
    Diaz, Romina G.
    Perez, Nestor G.
    Morgan, Patricio E.
    Villa-Abrille, Maria C.
    Caldiz, Claudia I.
    Nolly, Mariela B.
    Portiansky, Enrique L.
    Ennis, Irene L.
    Cingolani, Horacio E.
    HYPERTENSION, 2014, 63 (01) : 112 - 118
  • [39] Mineralocorticoid receptor antagonist use after hospitalization of patients with heart failure and post-discharge outcomes: a single-center retrospective cohort study
    Durstenfeld, Matthew S.
    Katz, Stuart D.
    Park, Hannah
    Blecker, Saul
    BMC CARDIOVASCULAR DISORDERS, 2019, 19 (01)
  • [40] Mineralocorticoid Receptor Antagonist for Renal Protection
    Ma, Terry King-Wing
    Szeto, Cheuk-Chun
    RENAL FAILURE, 2012, 34 (06) : 810 - 817
12345